 LA JOLLA, Calif., June 01, 2021 GLOBE NEWSWIRE -- Singular Genomics Systems, Inc. Singular Genomics, a company focused on delivering genomic technologies for the advancement of science and medicine, today announced the closing of its initial public offering of 11,730,000 shares of its common stock, which includes the full exercise of the underwriters option to purchase 1,530,000 additional shares of common stock, at a public offering price of 22.00 per share. 